Category list : Andrew Dillon
Stories with this category.
The National Institute for Health and Care Excellence has suspended with immediate effect its work to determine safe staffing levels across the NHS, an internal email has revealed.
The National Institute for Health and Care Excellence has recommended eculizumab (Soliris) for treating a rare life-threatening blood disorder called atypical Haemolytic Uraemic Syndrome (aHUS).
NICE has issued final draft guidance recommending lenalidomide, an immunomodulatory drug also known as Revlimid, as an option for treating myelodysplastic syndromes (MDS).